日本語 
Quali Corporation (hereinafter, Quali) has raised 1.8 billion yen in its Series A round through a third-party allotment of new shares, with Fast Track Initiative Inc. (FTI) and MedVenture Partners Inc. (MPI) as lead investors, and four other companies, including Sony Group Corporation (Sony) and Development Bank of Japan Inc. (DBJ).With this funding, the company will advance its business activities toward the social implementation of innovative robots that will advance surgical procedures in the field of microsurgery.
Surgical care is not only a life-saving technique, but also an essential part of social infrastructure for maintaining and improving the quality of life (QOL) of many people. Microsurgery is a type of surgical procedure used to treat functional disorders, and requires delicate work performed under a microscope. As a result, it requires high skill and extensive experience to acquire the expertise, and only a select few experienced surgeons are able to perform microsurgery, which poses a challenge to the further spread of this treatment method.
Also Read: Fujitsu Japan and JMDC Team Up on Healthcare Data
Quali is working to develop products and solutions that support microsurgery, aiming to solve problems in the medical field and improve people’s quality of life through technology centered on robotics. Going forward, Quali will inherit some of the technology cultivated in the Sony Group’s medical robotics research and accelerate the development of products and solutions for precise and safe microsurgery support robots that can be used in clinical settings.
SOURCE: PRTimes
English